Top Ten Topics in Clinical Cardiology 2024

1. Incorporate the latest developments within interventional cardiology and assess their effects on improving interventional outcomes and overall patient care.
2. Evaluate and differentiate between the newest innovative approaches in the treatment of heart failure to optimize patient management and care.
3. Identify the recent transcatheter tricuspid valve therapies.
4. Analyze the role of noninvasive testing in diagnosing coronary artery disease (CAD) and accurately provide prognostic information to guide patient treatment and care.
5. Apply evidence-based strategies for the prevention and management of hypertension to optimize blood pressure control and reduce cardiovascular risks in patients.
6. Assess the latest advancements in cardiac imaging technologies and their role in aiding accurate diagnoses and treatment planning for various cardiovascular conditions.
7. Learn the latest treatments for diabetes and obesity in CAD patients.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Deepak L Bhatt, MD, MPH, MBA, FACC, FAHA,FESC,MSCAI
Director of Mount Sinai Fuster Heart Hospital
Dr. Valentin Fuster Prof of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai, NY

Course Director, Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb|Stocks or stock options, excluding diversified mutual funds-Bristol Myers Squibb|Grant or research support-89 Bio|Grant or research support-Amgen|Grant or research support-Astrazeneca|Grant or research support-Bayer|Grant or research support-Boston Scientific|Grant or research support-Eli Lilly|Grant or research support-Janssen|Grant or research support-Novartis|Grant or research support-Novo Nordisk|Grant or research support-Pfizer Pharmaceuticals|Grant or research support-Sanofi Genzyme|Grant or research support-Afimmune|Grant or research support-Amarin|Grant or research support-Amgen|Grant or research support-Chiesi|Grant or research support-Faraday|Grant or research support-Fractyl|Grant or research support-Idorsia|Grant or research support-Lexicon|Grant or research support-Medtronic|Grant or research support-PhaseBio|Grant or research support-PLx Phama

Annapoorna S. Kini, MD, MRCP, FACC
Director, Cardiac Catheterization Laboratory/Interventional Cardiology Fellowship Program & Structural Heart Program
Director of Process Optimization System Catheterization Laboratories, Mount Sinai Health System

Course Director, Faculty

Nothing to disclose

Samin K. Sharma, MD, MSCAI, FACC
Director, Cardiovascular Clinical Institute/Senior Vice President, Operations and Quality, Mount Sinai Fuster Heart Hospital
Director, Interventional Cardiology, Mount Sinai Health System/ President Mount Sinai Heart Network

Course Director, Faculty

Nothing to disclose

Ron Blankstein, MD, FACC, FASNC, FASPC, MSCCT
Director, Cardiac Computed Tomography
Professor of Medicine and Radiology, Harvard Medical School
Boston, MA

Faculty

Advisor-Amgen|Advisor-Heartflow|Advisor-Caristo Inc, Nanox AI and Ehicid Inc

Marc Bonaca, MD, MPH
Executive Director, CPC Clinical Research
Associate Professor of Medicine, Cardiology, University of Colorado School of Medicine
Denver, CO

Faculty

Akshay Desai, MD, MPH
Medical Director, Cardiomyopathy and Cardiovascular Division, Brigham & Women's Hospital
Associate Professor, Harvard Medical School
Boston, MA

Faculty

Valentin Fuster, MD, PhD, MACC
Physician In Chief, Mount Sinai Hospital/President, Mount Sinai Fuster Heart Hospital
Prof. The Richard Gorlin, MD/Heart Research Foundation at The Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai

Faculty

Nothing to disclose

Mikhail N. Kosiborod, MD, FACC, FAHA
Vice President of Research, Saint Luke's Health System
Professor of Medicine, University of Missouri-Kansas City School of Medicine
Kansas City , MO

Faculty

Darren McGuire, MD, MHSc
Jere H. Mitchell, MD Distinguished Professor/Chair in Cardiovascular Science
University of Texas Southwestern Medical Center
Dallas, TX

Faculty

Roxana Mehran, MD, FACC, FAHA, MSCAI
Director of Interventional Cardiovascular Research and Clinical Trials
Professor of Medicine, Cardiology and of Population Health Science and Policy

Faculty

Grant or research support-Abbott, Abiomed, Alleviant Medical|Other: Personal Fees-AstraZeneca, Novartis, NovoNordisk|Consulting Fee-Medtronic|Consulting Fee-Novartis|Other: Personal Fees- Equity - Elixir Medical, ControlRad|Other: Personal Fees-OrbusNeich, Protembis, RM Global|Other: Personal Fees-Amgen, AstraZeneca, Boston Scientific|Other: Personal Fees-BMS, Chiesi, Concept Medical|Other: Personal Fees-Daiichi Sankyo, Element Science|Other: Personal Fees-Faraday, Janssen, Mediasphere|Other: Personal Fees-Medtelligence, Medtronic, Novartis|Other: Personal Fees-AMA, ACC, SCAI, Faculty CRF

David L. Reich, MD
President, The Mount Sinai Hospital and Mount Sinai Queens
Horace W. Goldsmith Professor, Anesthesiology Perioperative and Pain Medicine

Faculty

Nothing to disclose

Ph. Gabriel Steg, MD, FESC, FACC
Chief of Cardiology, Hospital Bichat
Assistant Publique-Hopitaux de Paris, Professor of Cardiology at Universite Paris
Paris, France

Faculty

Maria Giovanna Trivieri, MD, PhD
Medical Director, Pulmonary Hypertension Program
Associate Professor of Medicine, Cardiology, Icahn School of Medicine at Mount Sinai, NY

Faculty

Nothing to disclose

Friday, November 1, 2024